We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Report Europe - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Europe - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Europe: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Europe

The Europe medicaments containing insulin market shrank dramatically to $X in 2021, declining by -38.6% against the previous year. In general, consumption recorded a abrupt curtailment. The level of consumption peaked at $X in 2012; however, from 2013 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in Europe

In value terms, medicaments containing insulin production expanded rapidly to $X in 2021 estimated in export price. Over the period under review, production showed slight growth. The most prominent rate of growth was recorded in 2016 when the production volume increased by 19%. The level of production peaked at $X in 2017; however, from 2018 to 2021, production stood at a somewhat lower figure.

Medicaments Containing Insulin Exports

Exports in Europe

In 2021, the amount of medicaments containing insulin but not antibiotics exported in Europe skyrocketed to X tons, rising by 31% on the previous year's figure. In general, exports, however, recorded a abrupt contraction. The most prominent rate of growth was recorded in 2017 with an increase of 45%. As a result, the exports attained the peak of X tons. From 2018 to 2021, the growth of the exports failed to regain momentum.

In value terms, medicaments containing insulin exports surged to $X in 2021. Overall, exports, however, saw a deep setback. The level of export peaked at $X in 2017; however, from 2018 to 2021, the exports remained at a lower figure.

Exports by Country

Austria (X tons) and Belgium (X tons) were the largest exporters of medicaments containing insulin but not antibiotics in 2021, accounting for approx. 37% and 30% of total exports, respectively. Denmark (X tons) took the next position in the ranking, distantly followed by the UK (X tons). All these countries together took near 18% share of total exports. The Czech Republic (X tons), Norway (X tons), Slovakia (X tons) and Ireland (X tons) followed a long way behind the leaders.

From 2012 to 2021, the biggest increases were recorded for Ireland (with a CAGR of +135.0%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing insulin supplying countries in Europe were Austria ($X), Belgium ($X) and the Czech Republic ($X), together comprising 77% of total exports. These countries were followed by Denmark, the UK, Norway, Slovakia and Ireland, which together accounted for a further 9.8%.

Among the main exporting countries, Ireland, with a CAGR of +138.5%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in Europe stood at $X per ton in 2021, surging by 49% against the previous year. In general, the export price saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2016 an increase of 77%. As a result, the export price reached the peak level of $X per ton. From 2017 to 2021, the export prices remained at a somewhat lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2021, amid the top suppliers, the country with the highest price was the Czech Republic ($X per ton), while Denmark ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the UK (+19.5%), while the other leaders experienced more modest paces of growth.

Medicaments Containing Insulin Imports

Imports in Europe

Medicaments containing insulin imports dropped rapidly to X tons in 2021, declining by -60.6% compared with 2020 figures. In general, imports recorded a drastic downturn. The most prominent rate of growth was recorded in 2020 with an increase of 407% against the previous year. The volume of import peaked at X tons in 2012; however, from 2013 to 2021, imports failed to regain momentum.

In value terms, medicaments containing insulin imports contracted significantly to $X in 2021. Overall, imports saw a abrupt shrinkage. The pace of growth appeared the most rapid in 2016 with an increase of 160%. Over the period under review, imports attained the maximum at $X in 2013; however, from 2014 to 2021, imports remained at a lower figure.

Imports by Country

Denmark (X tons) represented roughly 97% of total imports in 2021.

Denmark was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics imports, with a CAGR of +27.5% from 2012 to 2021. From 2012 to 2021, the share of Denmark increased by +96 percentage points, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Denmark ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in Europe.

In Denmark, medicaments containing insulin imports increased at an average annual rate of +20.7% over the period from 2012-2021.

Import Prices by Country

In 2021, the import price in Europe amounted to $X per ton, growing by 95% against the previous year. In general, the import price showed a remarkable increase. The most prominent rate of growth was recorded in 2018 when the import price increased by 201% against the previous year. As a result, import price attained the peak level of $X per ton. From 2019 to 2021, the import prices remained at a somewhat lower figure.

As there is only one major supplying country, the average price level is determined by prices for Denmark.

From 2012 to 2021, the rate of growth in terms of prices for Denmark amounted to -5.3% per year.

Source: IndexBox Platform

This report provides an in-depth analysis of the medicaments containing insulin market in Europe. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Production in Europe, split by region and country
  • Trade (exports and imports) in Europe
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY

  8. 8. IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • Albania
    • Andorra
    • Austria
    • Belarus
    • Belgium
    • Bosnia and Herzegovina
    • Bulgaria
    • Croatia
    • Czech Republic
    • Denmark
    • Estonia
    • Faroe Islands
    • Finland
    • France
    • Germany
    • Gibraltar
    • Greece
    • Holy See
    • Hungary
    • Iceland
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg
    • North Macedonia
    • Malta
    • Moldova
    • Montenegro
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • San Marino
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland
    • Ukraine
    • United Kingdom
    • Liechtenstein
    • Isle of Man
    • Monaco

  12. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption, By Country, 2018–2023
    5. Production, In Physical Terms, By Country, 2012–2023
    6. Imports, In Physical Terms, By Country, 2012–2023
    7. Imports, In Value Terms, By Country, 2012–2023
    8. Import Prices, By Country Of Destination, 2012–2023
    9. Exports, In Physical Terms, By Country, 2012–2023
    10. Exports, In Value Terms, By Country, 2012–2023
    11. Export Prices, By Country Of Origin, 2012–2023

  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Consumption, By Country, 2023
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2023
    18. Production, In Value Terms, 2012–2023
    19. Production, By Country, 2023
    20. Production, In Physical Terms, By Country, 2012–2023
    21. Imports, In Physical Terms, 2012–2023
    22. Imports, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, By Country, 2023
    24. Imports, In Physical Terms, By Country, 2012–2023
    25. Imports, In Value Terms, By Country, 2012–2023
    26. Import Prices, By Country, 2012–2023
    27. Exports, In Physical Terms, 2012–2023
    28. Exports, In Value Terms, 2012–2023
    29. Exports, In Physical Terms, By Country, 2023
    30. Exports, In Physical Terms, By Country, 2012–2023
    31. Exports, In Value Terms, By Country, 2012–2023
    32. Export Prices, 2012–2023

Recommended reports

Asia - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 354

This report provides an in-depth analysis of the medicaments containing insulin market in Asia.

World - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 356

This report provides an in-depth analysis of the global medicaments containing insulin market.

EU - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 238

This report provides an in-depth analysis of the medicaments containing insulin market in the EU.

U.S. - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 297

This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..

China - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 248

This report provides an in-depth analysis of the medicaments containing insulin market in China.

Free Data: Medicaments Containing Insulin But Not Antibiotics - Europe
Table
Medicaments Containing Insulin But Not Antibiotics - Europe - Table
Dashboard
Medicaments Containing Insulin But Not Antibiotics - Europe - Dashboard
Report
Medicaments Containing Insulin But Not Antibiotics - Europe - Report